{'52WeekChange': -0.44183165,
 'SandP52WeekChange': None,
 'address1': '840 Memorial Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 4.59,
 'askSize': 800,
 'averageDailyVolume10Day': 253062,
 'averageVolume': 357325,
 'averageVolume10days': 253062,
 'beta': None,
 'beta3Year': None,
 'bid': 4.39,
 'bidSize': 900,
 'bookValue': 2.019,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cambridge',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.65,
 'dayLow': 4.3738,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.858,
 'enterpriseToRevenue': None,
 'enterpriseValue': 51727680,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '617-441-6243',
 'fiftyDayAverage': 5.127,
 'fiftyTwoWeekHigh': 8.81,
 'fiftyTwoWeekLow': 2.25,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 10871844,
 'forwardEps': -3.1,
 'forwardPE': -1.4225806,
 'fromCurrency': None,
 'fullTimeEmployees': 69,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.21711999,
 'heldPercentInstitutions': 0.63071,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/axcellahealth.com',
 'longBusinessSummary': 'Axcella Health Inc., a clinical-stage biotechnology '
                        'company, researches and develops endogenous metabolic '
                        'modulators (EMMs) for the treatment of complex '
                        'diseases and improving health in the United States. '
                        'It offers AXA1665 for use in treating overt hepatic '
                        'encephalopathy; AXA1125 and AXA1957 to treat '
                        'non-alcoholic steatohepatitis; AXA2678 for use in '
                        'treating muscle atrophy; and AXA4010 to target '
                        'multiple biological pathways to support normal '
                        'structures and functions of the blood. The company '
                        'was formerly known as Newco LS16, Inc. and changed '
                        'its name to Axcella Health Inc. in June 2016. Axcella '
                        'Health Inc. was founded in 2008 and is based in '
                        'Cambridge, Massachusetts.',
 'longName': 'Axcella Health Inc.',
 'market': 'us_market',
 'marketCap': 158049104,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_128680981',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -62473000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.51,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '857-320-2200',
 'previousClose': 4.51,
 'priceHint': 4,
 'priceToBook': 2.1842494,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.65,
 'regularMarketDayLow': 4.3738,
 'regularMarketOpen': 4.51,
 'regularMarketPreviousClose': 4.51,
 'regularMarketPrice': 4.51,
 'regularMarketVolume': 110845,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 35838800,
 'sharesPercentSharesOut': 0.01,
 'sharesShort': 359903,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 53328,
 'shortName': 'Axcella Health Inc.',
 'shortPercentOfFloat': 0.0179,
 'shortRatio': 1.12,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'AXLA',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.943,
 'twoHundredDayAverage': 4.5541005,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '5c672a04-a76f-3de0-8df0-a88741b38435',
 'volume': 110845,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.axcellahealth.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02139'}